Filing Details

Accession Number:
0000899243-17-004752
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-21 16:30:40
Reporting Period:
2017-02-17
Filing Date:
2017-02-21
Accepted Time:
2017-02-21 16:30:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1300858 Joseph Martin Joyce C/O Aldeyra Therapeutics, Inc.
131 Hartwell Avenue
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-17 4,444 $4.50 17,944 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017.